Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
Atherosclerosis represents an important chronic inflammatory process associated with several pathophysiological reactions in the vascular wall. The arachidonic acid, released by phospholipase A2, is an important substrate for the production of a group of lipid mediators known as leukotrienes, which...
Saved in:
Main Authors: | Graziano Riccioni, Alessandra Zanasi, Nicola Vitulano, Barbara Mancini, Nicolantonio D'Orazio |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2009/737282 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leukotrienes as Modifiers of Preclinical Atherosclerosis?
by: Graziano Riccioni, et al.
Published: (2012-01-01) -
Cytokine-Leukotriene Receptor Interactions
by: Marek Rola-Pleszczynski, et al.
Published: (2007-01-01) -
Role of Leukotrienes on Protozoan and Helminth Infections
by: Alexandre P. Rogerio, et al.
Published: (2012-01-01) -
Functional Properties and Molecular Architecture of Leukotriene A4 Hydrolase, a Pivotal Catalyst of Chemotactic Leukotriene Formation
by: Jesper Z. Haeggström, et al.
Published: (2002-01-01) -
Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis
by: Fufangyu Zhao, et al.
Published: (2025-02-01)